MS cuts rating on Enfusion stock after Clearwater’s acquisition bid
Go back to MS cuts rating on Enfusion stock after Clearwater’s acquisition bid| (NYSE: ENFN) | Delayed: 10.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.76 | 52 Week High | $ | |||
| Open | $10.76 | 52 Week Low | $ | |||
| Day High | $10.76 | P/E | N/A | |||
| Day Low | $10.76 | EPS | $ | |||
| Volume | 3,590 | |||||
| Morgan Stanley (NYSE: MS) | Delayed: 196.31 -0.01 (0.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $196.32 | 52 Week High | $39.88 | |||
| Open | $197.98 | 52 Week Low | $21.16 | |||
| Day High | $197.98 | P/E | 137.28 | |||
| Day Low | $194.25 | EPS | $1.43 | |||
| Volume | 4,527,290 | |||||
